NDC 80425-0292-01 - Cyclobenzaprine HCL ER
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0292
- Requested NDC
- 80425-0292-01
- Package NDCs from labels
- 80425-0292-1, 80425-0292-2, 80425-0292-3, 80425-0292-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cyclobenzaprine HCL ER - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0292-1 | Cyclobenzaprine HCLER | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 2 | |
| 80425-0292-2 | Cyclobenzaprine HCLER | 60 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 60 | 2 | |
| 80425-0292-3 | Cyclobenzaprine HCLER | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0292 | CYCLOBENZAPRINE HCL ER (CYCLOBENZAPRINE HCL) CAPSULE, EXTENDED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f8360da5-f1d3-1d89-e053-6294a90ad31c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0292-1 | EA - Each | 80425-0292 | 2e44b7d0-6868-4599-90e1-24ed3e9d2e0d | 1 | 2023-06-06 |
| 80425-0292-2 | EA - Each | 80425-0292 | b9d25f7c-b567-4941-b32c-9b6c1772fcda | 1 | 2023-06-06 |
| 80425-0292-3 | EA - Each | 80425-0292 | 6480d838-8c92-4e23-8982-918a017f2b7c | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclobenzaprine HCL | CYCLOBENZAPRINE HCL | Advanced Rx of Tennessee, LLC | afca2a49-6424-7b6a-e053-2a95a90ad41e | 2024-12-31 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine HCL | CYCLOBENZAPRINE HCL | Advanced Rx of Tennessee, LLC | afca1267-4d8f-7453-e053-2995a90a865c | 2024-12-31 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine HCL | CYCLOBENZAPRINE HCL | Advanced Rx of Tennessee, LLC | afcab35f-4ab9-33a4-e053-2a95a90ad529 | 2024-12-31 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | afcad582-ab59-4f70-e053-2a95a90a04e4 | 2024-12-31 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine HCL | CYCLOBENZAPRINE HCL | Advanced Rx of Tennessee, LLC | b062cb80-79a9-c5d8-e053-2a95a90aecfc | 2024-12-31 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine HCL | CYCLOBENZAPRINE HCL | Advanced Rx Pharmacy of Tennessee, LLC | c859f63a-09de-4eec-e053-2a95a90a312f | 2024-12-31 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine HCL ER | CYCLOBENZAPRINE HCL | Advanced Rx Pharmacy of Tennessee, LLC | f8360da5-f1d3-1d89-e053-6294a90ad31c | 2024-12-31 | Warnings, Adverse reactions | NDA021777 80425-0292-1 80425-0292-3 80425-0292-2 80425-0292 80425029201 828358 2a9bfe6a-6d67-b262-e063-6294a90a1cf3 f8360da5-f1d3-1d89-e053-6294a90ad31c 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | db49801d-9bde-5dd0-e053-2a95a90aee53 | 2024-12-26 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 2998c9e6-2f60-ef35-e063-6394a90a7bc7 | 2024-12-18 | Warnings, Adverse reactions | 828358 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Quality Care Products LLC | 794d350b-6c88-41d5-b68b-3e2c57ee2a4f | 2024-12-17 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | American Health Packaging | 5f321a03-ccfb-4c11-ac60-a461a5580c69 | 2024-12-13 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 4c51f56b-33c3-4611-bba8-876d9dde7aff | 2024-11-27 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 259fb05a-4f45-9c8e-e063-6294a90a4484 | 2024-10-29 | Warnings, Adverse reactions | NDA021777 828358 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | bfdd9460-5dfa-4588-8f4f-9d227c1717d5 | 2024-10-24 | Warnings, Adverse reactions | 828358 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Amneal Pharmaceuticals LLC | 390151d4-5fcb-46e2-92e6-de184827f43d | 2024-10-24 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 0a695685-cfec-464e-840c-32e3b7a68bd3 | 2024-08-21 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 193744c8-ff8e-4f65-aec1-1c13f471ac82 | 2024-08-21 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 59f31ca3-1b28-4768-bb29-520f06f4a9f5 | 2024-08-20 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE | NCS HealthCare of KY, LLC dba Vangard Labs | 53688de9-2031-4d19-b422-4000285f7f47 | 2024-08-12 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 1ac77323-7526-a129-e063-6394a90a641b | 2024-07-22 | Warnings, Adverse reactions | 0VE05JYS2P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.